Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Integrity Implant System Post Market Clinical Follow-Up Study

NCT: NCT06741527 · RECRUITING

NCT IDNCT06741527
StatusRECRUITING
Start Date2025-02-01
Completion2027-10
SponsorAnika Therapeutics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

Frequently Asked Questions

What is Integrity Implant System Post Market Clinical Follow-Up Study?

Integrity Implant System Post Market Clinical Follow-Up Study is a clinical trial registered under NCT06741527. Current status: RECRUITING.

What is the status of NCT06741527?

The current status of NCT06741527 (Integrity Implant System Post Market Clinical Follow-Up Study) is: RECRUITING.

When did Integrity Implant System Post Market Clinical Follow-Up Study start?

Integrity Implant System Post Market Clinical Follow-Up Study started on 2025-02-01.

Related Devices

K223538Integrity ImplantAnika Therapeutics, Inc. K173008SCS 17-01Anika Therapeutics, Inc. K190956SCS 17-01Anika Therapeutics, Inc. K212083Tactoset Injectable Bone SubstituteAnika Therapeutics, Inc. K222487Anika Tissue Tack Fixation SystemAnika Therapeutics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑